You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019550
Jan 202022222
Feb 2020383810
Mar 202045458
Apr 2020414120
May 2020454518
Jun 2020343413
Jul 2020202017
Aug 2020212119
Sep 2020373716
Oct 2020373727
Nov 2020313112
Dec 2020353515
Jan 2021313113
Feb 2021343420
Mar 2021484819
Apr 2021252516
May 2021191911
Jun 2021484833
Jul 2021525240
Aug 2021727271
Sep 2021515160
Oct 2021333329
Nov 2021343430
Dec 2021353512
Jan 2022333612
Feb 2022282917
Mar 2022243217
Apr 2022454531
May 2022404233
Jun 2022646519
Jul 2022303310
Aug 202234348
Sep 2022262849
Oct 2022121210
Nov 2022232314
Dec 2022272817
Jan 2023232311
Feb 2023171711
Mar 2023353512
Apr 202310105
May 2023191912
Jun 2023353618
Jul 2023212115
Aug 2023242412
Sep 2023424213
Oct 2023979728
Nov 202391917
Dec 2023292912
Jan 2024252518
Feb 2024242415
Mar 2024303114
Total18011824971